Buscar
Congreso SOLACI

Búsqueda de: restenosis

Si no está conforme con los resultados, inténtelo de nuevamente.
Coronary disease

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous...
Dr. Andrés Rodríguez -
Ir
Acute coronary syndromes

TCT 2025 | SELUTION4ISR: sirolimus-eluting balloon for in-stent restenosis

In-stent restenosis (ISR) continues to be a relevant clinical challenge in contemporary PCI practice. In the DES...
Dr. Omar Tupayachi -
Ir
Chronic Coronary Syndromes

Long Term Outcomes of RIBS VI, a Study on Bioresorbable Stents in Patients with In-Stent Restenosis

The use of drug eluting stents (DES) is currently recommended for the percutaneous treatment of coronary artery...
Dr. Andrés Rodríguez -
Ir
Coronary disease

Biolimus vs Paclitaxel Coated Balloons for the Treatment of In-Stent Restenosis

Drug eluting stent (DES) in-stent restenosis (ISR) is currently a challenging, seeing as it often requires repeat...
solaci -
Ir
Coronary disease

Treatment of Recurrent In-Stent Restenosis with Drug-Eluting Stents: 10-Year Outcomes

In-stent restenosis (ISR) remains the main limitation in the percutaneous treatment of coronary artery disease, with a...
solaci -
Ir
Coronary disease

AGENT-IDE: Drug Coated Balloons for Instent Restenosis

Drug eluting stents (DES) have improved considerably over the years, reducing the initial indices of instent restenosis...
solaci -
Ir
Coronary disease

Recurrent Revascularization at 10 Years after Percutaneous Treatment of DES In-Stent Restenosis

In stent restenosis (ISR) continues to be the main limitation to the percutaneous treatment of coronary artery...
solaci -
Ir
Coronary disease

TCT 2023 | In Stent Restenosis: Sirolimus vs. Paclitaxel Coated Balloons

This was a prospective, multicenter, randomized study including 130 patients with instent restenosis treated with sirolimus coated...
solaci -
Ir

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Comparison of strategies: NMA of IVUS, OCT, or angiography in complex lesions

Dr. Omar Tupayachi - 0
Percutaneous coronary intervention (PCI) in complex lesions continues to represent a technical challenge in contemporary interventional cardiology. Angiography, although it remains the most widely...

Is upper-limb aerobic training an effective alternative to lower-limb exercise in peripheral artery disease?

Dr. Juan Manuel Pérez - 0
Peripheral artery disease is associated with impaired functional capacity, reduced walking distance, and poorer quality of life, and structured exercise is a class I...

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Dr. Juan Manuel Pérez - 0
Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Noticias Institucionales

Advanced Postgraduate Course in Hemodynamics and Interventional Cardiology – 2026 Edition

solaci - 0
Registration is now open for the SOLACI–CACI Advanced Postgraduate Course in Hemodynamics and Interventional Cardiology – 2026 Edition. The program is intended for physicians with...

SOLACI Wishes You Happy Holidays

solaci - 0
From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

solaci - 0
The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad